COVID-19 and congenital, structural and valvar heart disease interventions
from 16:00 CEST
Moderator: Shakeel Qureshi
Moderator
- Shakeel Qureshi, Evelina Children's Hospital, London, UK
Panelist
- Horst Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Q&A facilitators
- Sameer Gafoor, Swedish Heart and Vascular Institute, Seattle, USA
- Kolja Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Program
- Kawasaki disease and pediatric multisystem inflammatory syndrome (PMIS)Simona Marcora, Papa Giovanni XXIII Hospital, Bergamo, Italy
- Potential role of ASD and PFO in embolic eventsBernhard Meier, Inselspital, Bern, Switzerland
- Myocarditis: incidence, diagnosis and managementHeinz-Peter Schultheiss, Institut Kardiale Diagnostik und Therapie (IKDT), Berlin, Germany
- Advanced cardiovascular support in Covid-19 patientsEric Gnall, Lankenau Institute for Medical Research, Philadelphia, USA
- Managing a congenital, structural and valvar cathlab during and after Covid-19Mario Carminati, I.R.C.C.S. Policlinico San Donato, Milan, Italy Keyhan Sayadpour, Tehran University of Medical Sciences, Tehran, Iran